Literature DB >> 18800985

Interferon-gamma priming is involved in the activation of arginase by oligodeoxinucleotides containing CpG motifs in murine macrophages.

Miriam V Liscovsky1, Romina P Ranocchia, Carolina V Gorlino, Diego O Alignani, Gabriel Morón, Belkys A Maletto, María C Pistoresi-Palencia.   

Abstract

Recognition of microbial products by macrophages (Mphi) stimulates an inflammatory response and plays a critical role in directing the host immune response against infection. In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (CpG) are able to stimulate, in the presence of interferon-gamma (IFN-gamma), both arginase and inducible nitric oxide synthase (iNOS) in murine Mphi. Unexpectedly, IFN-gamma, a cytokine believed to be an inhibitor of arginase activity, intervened in the activation of this enzyme. A significant increase in arginase activity was observed upon a short pre-incubation (1 hr) with IFN-gamma and subsequent CpG stimulation. Therefore, a very interesting observation of this study was that the CpG-mediated arginase activity is dependent on IFN-gamma priming. The increase in arginase activity as a result of stimulation with CpG plus IFN-gamma was correlated with augmented expression of the arginase II isoform. The use of pharmacological specific inhibitors revealed that arginase activity was dependent on p38 mitogen-activated protein kinase (MAPK) and extracellular signal-regulated protein kinase (ERK), but independent of c-Jun N-terminal kinase (JNK) activation. This report reveals a singular effect of the combination of CpG and IFN-gamma, one of the mayor cytokines produced in response to CpG administration in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18800985      PMCID: PMC2753963          DOI: 10.1111/j.1365-2567.2008.02938.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  47 in total

1.  CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.

Authors:  R D Weeratna; C L Brazolot Millan; M J McCluskie; H L Davis
Journal:  FEMS Immunol Med Microbiol       Date:  2001-12

Review 2.  CpG motifs in bacterial DNA and their immune effects.

Authors:  Arthur M Krieg
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

3.  Sustained nitric oxide production in macrophages requires the arginine transporter CAT2.

Authors:  B Nicholson; C K Manner; J Kleeman; C L MacLeod
Journal:  J Biol Chem       Date:  2001-02-16       Impact factor: 5.157

4.  Selective roles of MAPKs during the macrophage response to IFN-gamma.

Authors:  Annabel F Valledor; Ester Sánchez-Tilló; Luis Arpa; Jin Mo Park; Carme Caelles; Jorge Lloberas; Antonio Celada
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

5.  Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism.

Authors:  M Hesse; M Modolell; A C La Flamme; M Schito; J M Fuentes; A W Cheever; E J Pearce; T A Wynn
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

6.  Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in mice.

Authors:  X Martinez; X Li; J Kovarik; M Klein; P H Lambert; C A Siegrist
Journal:  Eur J Immunol       Date:  1999-10       Impact factor: 5.532

7.  Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs.

Authors:  A H Dalpke; S Opper; S Zimmermann; K Heeg
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

Review 8.  Nitric oxide and the immune response.

Authors:  C Bogdan
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

9.  Enhanced murine macrophage TNF receptor shedding by cytosine-guanine sequences in oligodeoxynucleotides.

Authors:  L Jin; D P Raymond; T D Crabtree; S J Pelletier; C W Houlgrave; T L Pruett; R G Sawyer
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

Review 10.  Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling.

Authors:  Chilakamarti V Ramana; M Pilar Gil; Robert D Schreiber; George R Stark
Journal:  Trends Immunol       Date:  2002-02       Impact factor: 16.687

View more
  13 in total

1.  Hyperglycemia-impaired aortic vasorelaxation mediated through arginase elevation: Role of stress kinase pathways.

Authors:  Surabhi Chandra; David J R Fulton; Ruth B Caldwell; R William Caldwell; Haroldo A Toque
Journal:  Eur J Pharmacol       Date:  2018-11-28       Impact factor: 4.432

2.  Mice deficient in Mkp-1 develop more severe pulmonary hypertension and greater lung protein levels of arginase in response to chronic hypoxia.

Authors:  Yi Jin; Thomas J Calvert; Bernadette Chen; Louis G Chicoine; Mandar Joshi; John Anthony Bauer; Yusen Liu; Leif D Nelin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-02-19       Impact factor: 4.733

Review 3.  The Arginase Pathway in Neonatal Brain Hypoxia-Ischemia.

Authors:  Jana Krystofova; Praneeti Pathipati; Jeffrey Russ; Ann Sheldon; Donna Ferriero
Journal:  Dev Neurosci       Date:  2019-04-17       Impact factor: 2.984

4.  p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated mice.

Authors:  Haroldo A Toque; Maritza J Romero; Rita C Tostes; Alia Shatanawi; Surabhi Chandra; Zidonia N Carneiro; Edward W Inscho; Robert Clinton Webb; Ruth B Caldwell; Robert William Caldwell
Journal:  J Sex Med       Date:  2010-08-30       Impact factor: 3.802

5.  Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation.

Authors:  Haroldo A Toque; Kenia P Nunes; Lin Yao; James K Liao; R Clinton Webb; Ruth B Caldwell; R William Caldwell
Journal:  J Sex Med       Date:  2013-04-08       Impact factor: 3.802

Review 6.  Myeloid-derived suppressor cells: the dark knight or the joker in viral infections?

Authors:  Celeste Goh; Sowmya Narayanan; Young S Hahn
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

Review 7.  Arginine-dependent immune responses.

Authors:  Adrià-Arnau Martí I Líndez; Walter Reith
Journal:  Cell Mol Life Sci       Date:  2021-05-26       Impact factor: 9.261

8.  Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment.

Authors:  María F Harman; Romina P Ranocchia; Carolina V Gorlino; María F Sánchez Vallecillo; Sofía D Castell; María I Crespo; Belkys A Maletto; Gabriel Morón; María C Pistoresi-Palencia
Journal:  Oncotarget       Date:  2015-05-30

Review 9.  Functions of arginase isoforms in macrophage inflammatory responses: impact on cardiovascular diseases and metabolic disorders.

Authors:  Zhihong Yang; Xiu-Fen Ming
Journal:  Front Immunol       Date:  2014-10-27       Impact factor: 7.561

10.  Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation.

Authors:  Zhihong Yang; Xiu-Fen Ming
Journal:  Front Immunol       Date:  2013-06-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.